Ozdemir Halil, Tacyildiz Nurdan, Unal Emel, Yavuz Gulsan, Ugur Handan, Gunduz Kaan
Department of Pediatrics, Ankara University School of Medicine, Ankara, Turkey.
Pediatr Hematol Oncol. 2007 Apr-May;24(3):221-31. doi: 10.1080/08880010601107623.
Advanced intraocular tumors and metastatic disease in retinoblastoma patients still occur frequently in developing countries. The aim of this retrospective study was to describe the clinical and epidemiological characteristics of patients with retinoblastoma and the effects of these features on disease prognosis in the authors' pediatric oncology unit as a developing country profile to define the problem. A retrospective chart review of 91 patients who presented to the unit between May 1996 and December 2003 was conducted in this study. Patients with unilateral disease presented at a median age of 24 months and those with bilateral disease at a median age of 9.5 months (p < .01). Most of the eyes with retinoblastoma (68.6%) had Reese-Ellsworth stage V disease. Metastatic disease was diagnosed in 19 (20.9%) patients. Cases with metastatic disease presented at a median age of 24 months and those without metastatic disease at a median age of 12.5 months (p < .05). In 31 patients (34.1%) there was a delay in diagnosis. The enucleation ratio in eyes with advanced intraocular stage was significantly higher than in eyes with early intraocular stage (57.9 vs. 3.8%) (p < .001). In patients with metastatic disease, tumor recurrence was more frequent than in the nonmetastatic patients (36.8 vs. 4.2%) (p < .01). Seven children (7.7%) died due to central nervous system (CNS) metastasis (p < .01). Advanced intraocular disease and distant metastases occur more frequently in Turkish children with retinoblastoma than in children in developed countries, causing a higher rate of enucleation and mortality. Late referral might account for the delayed diagnosis.
在发展中国家,视网膜母细胞瘤患者中晚期眼内肿瘤和转移性疾病仍然频繁发生。本回顾性研究的目的是描述视网膜母细胞瘤患者的临床和流行病学特征,以及这些特征对作者所在儿科肿瘤病房疾病预后的影响,作为发展中国家的一个案例来界定问题。本研究对1996年5月至2003年12月期间在该病房就诊的91例患者进行了回顾性病历审查。单侧疾病患者的中位年龄为24个月,双侧疾病患者的中位年龄为9.5个月(p<0.01)。大多数视网膜母细胞瘤患眼(68.6%)处于里斯-埃尔斯沃思Ⅴ期疾病。19例(20.9%)患者被诊断为转移性疾病。有转移性疾病的病例中位年龄为24个月,无转移性疾病的病例中位年龄为12.5个月(p<0.05)。31例患者(34.1%)存在诊断延迟。眼内晚期患者的眼球摘除率显著高于眼内早期患者(57.9%对3.8%)(p<0.001)。有转移性疾病的患者肿瘤复发比无转移性疾病的患者更频繁(36.8%对4.2%)(p<0.01)。7名儿童(7.7%)因中枢神经系统转移而死亡(p<0.01)。与发达国家的儿童相比,土耳其视网膜母细胞瘤患儿眼内晚期疾病和远处转移更频繁,导致更高的眼球摘除率和死亡率。延迟转诊可能是诊断延迟的原因。